Abhijeet Pataskar
YOU?
Author Swipe
View article: Adoptive T cell therapy targeting an inducible and broadly shared product of aberrant mRNA translation
Adoptive T cell therapy targeting an inducible and broadly shared product of aberrant mRNA translation Open
Prolonged exposure to interferon-gamma (IFNγ) and the associated increased expression of the enzyme indoleamine 2,3-dioxygenase 1 (IDO1) create an intracellular shortage of tryptophan in the cancer cells, which stimulates ribosomal framesh…
View article: Chemotherapeutic agents and leucine deprivation induce codon-biased aberrant protein production in cancer
Chemotherapeutic agents and leucine deprivation induce codon-biased aberrant protein production in cancer Open
Messenger RNA (mRNA) translation is a tightly controlled process frequently deregulated in cancer. Key to this deregulation are transfer RNAs (tRNAs), whose expression, processing and post-transcriptional modifications are often altered in…
View article: Arginine deprivation enriches lung cancer proteomes with cysteine by inducing arginine-to-cysteine substitutants
Arginine deprivation enriches lung cancer proteomes with cysteine by inducing arginine-to-cysteine substitutants Open
View article: ABPEPserver: a web application for documentation and analysis of substitutants
ABPEPserver: a web application for documentation and analysis of substitutants Open
View article: Alternative cleavage and polyadenylation generates downstream uncapped RNA isoforms with translation potential
Alternative cleavage and polyadenylation generates downstream uncapped RNA isoforms with translation potential Open
View article: Boosting Antitumor Immunity with an Expanded Neoepitope Landscape
Boosting Antitumor Immunity with an Expanded Neoepitope Landscape Open
Immune-checkpoint blockade therapy has been successfully applied to many cancers, particularly tumors that harbor a high mutational burden and consequently express a high abundance of neoantigens. However, novel approaches are needed to im…
View article: Author Correction: Tryptophan depletion results in tryptophan-to-phenylalanine substitutants
Author Correction: Tryptophan depletion results in tryptophan-to-phenylalanine substitutants Open
View article: Suppression of heparan sulfation re-sensitizes YAP1-driven melanoma to MAPK pathway inhibitors
Suppression of heparan sulfation re-sensitizes YAP1-driven melanoma to MAPK pathway inhibitors Open
View article: Tryptophan depletion results in tryptophan-to-phenylalanine substitutants
Tryptophan depletion results in tryptophan-to-phenylalanine substitutants Open
View article: Oncogene-dependent sloppiness in mRNA translation
Oncogene-dependent sloppiness in mRNA translation Open
View article: A comprehensive enhancer screen identifies TRAM2 as a key and novel mediator of YAP oncogenesis
A comprehensive enhancer screen identifies TRAM2 as a key and novel mediator of YAP oncogenesis Open
View article: Additional file 9 of A comprehensive enhancer screen identifies TRAM2 as a key and novel mediator of YAP oncogenesis
Additional file 9 of A comprehensive enhancer screen identifies TRAM2 as a key and novel mediator of YAP oncogenesis Open
Additional file 9: Table S8. RNA-seq data analysis of MCF10A-YAP5SA and MCF10A-TRAM2 cells.
View article: Additional file 5 of A comprehensive enhancer screen identifies TRAM2 as a key and novel mediator of YAP oncogenesis
Additional file 5 of A comprehensive enhancer screen identifies TRAM2 as a key and novel mediator of YAP oncogenesis Open
Additional file 5: Table S4. RNA-seq to identify the target genes of validated enhancers.
View article: Additional file 2 of A comprehensive enhancer screen identifies TRAM2 as a key and novel mediator of YAP oncogenesis
Additional file 2 of A comprehensive enhancer screen identifies TRAM2 as a key and novel mediator of YAP oncogenesis Open
Additional file 2: Table S1. CRISPR-YAP-enh-lib sequences.
View article: Additional file 4 of A comprehensive enhancer screen identifies TRAM2 as a key and novel mediator of YAP oncogenesis
Additional file 4 of A comprehensive enhancer screen identifies TRAM2 as a key and novel mediator of YAP oncogenesis Open
Additional file 4: Table S3. CRISPR screen selected hits.
View article: Additional file 10 of A comprehensive enhancer screen identifies TRAM2 as a key and novel mediator of YAP oncogenesis
Additional file 10 of A comprehensive enhancer screen identifies TRAM2 as a key and novel mediator of YAP oncogenesis Open
Additional file 10: Table S9. RNA-seq data analysis of TRAM2-KO in MCF10A-YAP5SA cells.
View article: Additional file 3 of A comprehensive enhancer screen identifies TRAM2 as a key and novel mediator of YAP oncogenesis
Additional file 3 of A comprehensive enhancer screen identifies TRAM2 as a key and novel mediator of YAP oncogenesis Open
Additional file 3: Table S2. CRISPR screen analysis.
View article: Additional file 8 of A comprehensive enhancer screen identifies TRAM2 as a key and novel mediator of YAP oncogenesis
Additional file 8 of A comprehensive enhancer screen identifies TRAM2 as a key and novel mediator of YAP oncogenesis Open
Additional file 8: Table S7. Proteomics data analysis TRAM2-KO in MDA-MB-231 cells.
View article: Additional file 6 of A comprehensive enhancer screen identifies TRAM2 as a key and novel mediator of YAP oncogenesis
Additional file 6 of A comprehensive enhancer screen identifies TRAM2 as a key and novel mediator of YAP oncogenesis Open
Additional file 6: Table S5. Proteomics data analysis of MCF10A-YAP5SA and MCF10A-TRAM2 cells.
View article: Additional file 11 of A comprehensive enhancer screen identifies TRAM2 as a key and novel mediator of YAP oncogenesis
Additional file 11 of A comprehensive enhancer screen identifies TRAM2 as a key and novel mediator of YAP oncogenesis Open
Additional file 11: Table S10. Primers for ChIP-qPCR, 3C, q-PCR and gene knockout.
View article: Additional file 7 of A comprehensive enhancer screen identifies TRAM2 as a key and novel mediator of YAP oncogenesis
Additional file 7 of A comprehensive enhancer screen identifies TRAM2 as a key and novel mediator of YAP oncogenesis Open
Additional file 7: Table S6. Proteomics data analysis of TRAM2-KO in MCF10A-YAP5SA cells.
View article: Anti-tumour immunity induces aberrant peptide presentation in melanoma
Anti-tumour immunity induces aberrant peptide presentation in melanoma Open
View article: Deciphering the Gene Regulatory Landscape Encoded in DNA Biophysical Features
Deciphering the Gene Regulatory Landscape Encoded in DNA Biophysical Features Open
View article: <scp>SLC</scp> 1A3 contributes to L‐asparaginase resistance in solid tumors
<span>SLC</span> 1A3 contributes to L‐asparaginase resistance in solid tumors Open
L-asparaginase (ASNase) serves as an effective drug for adolescent acute lymphoblastic leukemia. However, many clinical trials indicated severe ASNase toxicity in patients with solid tumors, with resistant mechanisms not well understood. H…
View article: Assessment and site-specific manipulation of DNA (hydroxy-)methylation during mouse corticogenesis
Assessment and site-specific manipulation of DNA (hydroxy-)methylation during mouse corticogenesis Open
Dynamic changes in DNA (hydroxy-)methylation are fundamental for stem cell differentiation. However, the signature of these epigenetic marks in specific cell types during corticogenesis is unknown. Moreover, site-specific manipulation of c…
View article: Stage-Specific Transcription Factors Drive Astrogliogenesis by Remodeling Gene Regulatory Landscapes
Stage-Specific Transcription Factors Drive Astrogliogenesis by Remodeling Gene Regulatory Landscapes Open
A broad molecular framework of how neural stem cells are specified toward astrocyte fate during brain development has proven elusive. Here we perform comprehensive and integrated transcriptomic and epigenomic analyses to delineate gene reg…
View article: Direct pericyte-to-neuron reprogramming via unfolding of a neural stem cell-like program
Direct pericyte-to-neuron reprogramming via unfolding of a neural stem cell-like program Open
View article: FBXO32 promotes microenvironment underlying epithelial-mesenchymal transition via CtBP1 during tumour metastasis and brain development
FBXO32 promotes microenvironment underlying epithelial-mesenchymal transition via CtBP1 during tumour metastasis and brain development Open
View article: ERK signalling modulates epigenome to drive epithelial to mesenchymal transition
ERK signalling modulates epigenome to drive epithelial to mesenchymal transition Open
The series of events that allow the conversion from adherent epithelial cells into migratory cells is collectively known as epithelial-mesenchymal transition (EMT). EMT is employed during embryonic development such as for gastrulation and …
View article: Highlights of the 1st Student Symposium on Computational Genomics
Highlights of the 1st Student Symposium on Computational Genomics Open
On 30 November 2016, over 70 junior researchers in computational biology from diverse countries met in Mainz, Germany, for the 1st Student Symposium on Computational Genomics. Overall, the symposium was a great success and featured four ou…